Investments, Funding & Disinvestment
-
Africa secures USD234M in Pandemic Fund approvals at Kigali meeting
The approved funding will help countries build systems that keep communities safe, particularly in cross-border areas where health risks are highest.
-
Biogen completes USD85M acquisition of Alcyone Therapeutics to advance CNS drug delivery technology
The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.
-
Moderna invests USD140M to expand US manufacturing capabilities at Massachusetts facility
Construction at the MTC is currently underway and is scheduled for completion during the first half of 2027.
-
MSD acquires Cidara Therapeutics for USD9.2B to strengthen influenza prevention pipeline
The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).
-
GE HealthCare acquires Intelerad for USD2.3B to expand cloud-based imaging solutions
The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.
-
Rwanda launches construction of new veterinary lab to end dependence on overseas sample testing
This new facility will replace the existing laboratory, which Minister of Agriculture and Animal Resources Mark Cyubahiro Bagabe noted has served for nearly four decades and no longer meets current needs.